VeriMomapigenin est-il sûr pendant la grossesse ?
No EU Annex II/III listing or harmonised CLP reproductive/CMR classification was found for apigenin (CAS 520-36-5), and no authoritative CIR/SCCS safety opinion identifying a reproductive hazard was found; peer‑reviewed literature reports in‑vitro estrogenic/sex‑hormone–modulating activity for apigenin (mechanistic evidence) but not clear human teratogenic or harmonised animal reproductive hazard leading to regulatory classification, so hazard = 0; mechanism = 2 because in‑vitro estrogenic and endocrine‑modulating activity has been demonstrated. Topical dermal absorption from cosmetics is reported as low but measurable depending on formulation (ex vivo permeation varies with vehicle), therefore exposure = 1. � Sources: PubMed/PMC reviews on apigenin bioactivity and skin use; ex vivo skin permeation review; COSING/ingredient databases.
Pregnancy-safe products containing apigenin
Related ingredients
Frequently asked questions
- apigenin est-il sûr pendant la grossesse ?
- No EU Annex II/III listing or harmonised CLP reproductive/CMR classification was found for apigenin (CAS 520-36-5), and no authoritative CIR/SCCS safety opinion identifying a reproductive hazard was found; peer‑reviewed literature reports in‑vitro estrogenic/sex‑hormone–modulating activity for apigenin (mechanistic evidence) but not clear human teratogenic or harmonised animal reproductive hazard leading to regulatory classification, so hazard = 0; mechanism = 2 because in‑vitro estrogenic and endocrine‑modulating activity has been demonstrated. Topical dermal absorption from cosmetics is reported as low but measurable depending on formulation (ex vivo permeation varies with vehicle), therefore exposure = 1. � Sources: PubMed/PMC reviews on apigenin bioactivity and skin use; ex vivo skin permeation review; COSING/ingredient databases.
- apigenin est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no regulatory reproductive/CMR classification or CIR/SCCS restriction found. Mechanistic data show apigenin can modulate hormone pathways (in vitro) which is relevant to lactation physiology but no convincing data show human reproductive or lactation toxicity. Dermal exposure from cosmetics is low but measurable, so adult breastfeeding exposure = 1. Sources: peer‑reviewed reviews on apigenin pharmacology and topical use; COSING/EWG entries.
- apigenin est-il sûr pour la peau de bébé ?
- No infant‑specific developmental toxicity or dermal teratogenicity data were found and no regulatory ban/restriction for apigenin. Mechanistic evidence (in‑vitro estrogenic/endocrine‑modulating activity) remains (m=2). Exposure score increased by +1 for infants (e=2) because topical absorption through infant skin is higher (immature barrier, higher surface‑area‑to‑weight) and formulation/permeation studies show apigenin can permeate skin depending on vehicle; therefore infant dermal exposure is likely higher than adult. Sources: reviews showing skin permeation and cosmetic use, PubMed mechanistic literature, COSING database.
- Comment VeriMom évalue-t-il apigenin ?
- VeriMom évalue apigenin à 80/100 (risque faible) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à apigenin pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à apigenin basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.